Your browser doesn't support javascript.
loading
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.
de Nonneville, Alexandre; Salas, Sébastien; Bertucci, François; Sobinoff, Alexander P; Adélaïde, José; Guille, Arnaud; Finetti, Pascal; Noble, Jane R; Churikov, Dimitri; Chaffanet, Max; Lavit, Elise; Pickett, Hilda A; Bouvier, Corinne; Birnbaum, Daniel; Reddel, Roger R; Géli, Vincent.
Afiliação
  • de Nonneville A; Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Team « Telomere and Chromatin ¼. Equipe labellisée Ligue Nationale Contre Le Cancer, Aix-Marseille Univ, Marseille, France.
  • Salas S; Cancer Research Unit, Faculty of Medicine and Health, Children's Medical Research Institute, University of Sydney, Westmead, NSW, Australia.
  • Bertucci F; Predictive Oncology Laboratory, Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
  • Sobinoff AP; Department of Medical Oncology, CRCM, CNRS, INSERM, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
  • Adélaïde J; Department of Medical Oncology, Assistance Publique Hôpitaux de Marseille - Timone Hospital, Marseille, France.
  • Guille A; Predictive Oncology Laboratory, Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
  • Finetti P; Department of Medical Oncology, CRCM, CNRS, INSERM, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
  • Noble JR; Telomere Length Regulation Unit, Faculty of Medicine and Health, Children's Medical Research Institute, University of Sydney, Westmead, NSW, Australia.
  • Churikov D; Predictive Oncology Laboratory, Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
  • Chaffanet M; Predictive Oncology Laboratory, Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
  • Lavit E; Predictive Oncology Laboratory, Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
  • Pickett HA; Cancer Research Unit, Faculty of Medicine and Health, Children's Medical Research Institute, University of Sydney, Westmead, NSW, Australia.
  • Bouvier C; Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Team « Telomere and Chromatin ¼. Equipe labellisée Ligue Nationale Contre Le Cancer, Aix-Marseille Univ, Marseille, France.
  • Birnbaum D; Predictive Oncology Laboratory, Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
  • Reddel RR; Department of Medical Oncology, Assistance Publique Hôpitaux de Marseille - Timone Hospital, Marseille, France.
  • Géli V; Telomere Length Regulation Unit, Faculty of Medicine and Health, Children's Medical Research Institute, University of Sydney, Westmead, NSW, Australia.
EMBO Mol Med ; 14(10): e15859, 2022 10 10.
Article em En | MEDLINE | ID: mdl-35920001
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteossarcoma / DNA Topoisomerases Tipo I / Proteína Nuclear Ligada ao X Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteossarcoma / DNA Topoisomerases Tipo I / Proteína Nuclear Ligada ao X Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article